MRI-guided radiation for advanced lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new way of giving radiation therapy for advanced lung cancer that cannot be surgically removed. It uses MRI scans to guide and adjust the radiation dose, which may help target the tumor more precisely and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have stage III non-small cell lung cancer that cannot be removed by surgery.
- You have not had radiation therapy or surgery for this cancer.
- You are generally well enough to do daily activities (performance status 0 or 1).
- You can safely have an MRI scan (no metal implants or pacemaker that prevents it).
- Your blood counts and organ function (kidney, liver, lungs) are within certain limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests a new combination of treatments for advanced non-small cell lung cancer (NSCLC) that has not been treated before. It combines a type of immunotherapy (envafolimab) with a drug that may slow blood vessel growth (endostar) and a special type of radiation therapy (SRT). This may help shrink tumors and control the cancer for a longer time.
This study tests a new way to plan radiation therapy for lung cancer using a special MRI scan with a harmless gas (xenon) to see which parts of your lungs work best. The goal is to target radiation away from healthy lung tissue, which may reduce side effects, especially for people who have had radiation before or have lung conditions like COPD.
This trial tests a personalized approach using MRI to guide chemotherapy and radiation, combined with immunotherapy, for advanced esophageal cancer that cannot be removed by surgery or has spread to nearby lymph nodes. It aims to improve treatment effectiveness while managing side effects.
This trial tests a new way to plan radiation therapy for lung cancer by using a special imaging technique (functional lung imaging) to see which parts of your lungs work best. The goal is to reduce damage to healthy lung tissue while still targeting the cancer.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.